Home › Moberg Pharma announces successful results for MOB-015 in a Phase II...
 

Keywords :   


Moberg Pharma announces successful results for MOB-015 in a Phase II...

2014-09-17 10:42:21| Appliances - Topix.net

Moberg Pharma AB announces successful top-line results from a phase II study for MOB-015 in onychomycosis . The primary endpoint, mycological cure after 15 months, was achieved in 54% of the patients.

Tags: results ii successful phase

Category:Consumer Goods and Services

Latest from this category

All news
27.11Interra adds Netflix VMAF video quality assessment support
27.11Brightcove to be acquired by Bending Spoons
27.11FOX, Disney capitalize on multiplatform TV footprint in October
27.11Tele Columbus TV households down 40% YoY in 3Q 2024
27.11'It's going to be hard': US firms race to get ahead of Trump tariffs
27.11Loyalty cards offer genuine savings, says watchdog
27.11Aston Martin issues second profit warning in two months
27.11Online slots gambling to be limited to 5 per spin
Consumer Goods and Services »
27.11
27.11240
27.11 C.J.Date
27.11VR7001
27.11BEAST
27.11
27.11
27.11 112
More »